SCHEMBL1801537

SCHEMBL1801537

O=P(CCCP(=O)(c1ccccc1)c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.86

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.86
NPSR1 Q6W5P4 3/20 0.86
GAA P10253 2/20 0.86
MAPT P10636 2/20 0.86
ALPG P10696 1/20 0.86
ALOX12 P18054 1/20 0.86
NPY1R P25929 1/20 0.86
HTT P42858 1/20 0.86
NPY2R P49146 1/20 0.86
KMT2A Q03164 5/20 0.64
MEN1 O00255 4/20 0.64
L3MBTL1 Q9Y468 1/20 0.57
POLB P06746 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
USP2 O75604 2/20 0.54
CFTR P13569 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
LMNA P02545 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrogen Peroxide SCHEMBL8610678 0.97 ALDH1A1 (0.82) ALDH1A1NPSR1GAAMAPTALPG
SCHEMBL4162470 0.95 ALDH1A1 (0.95) ALDH1A1NPSR1GAAMAPTALPG
SCHEMBL14493538 0.92 ALDH1A1 (1.00) ALDH1A1NPSR1GAAMAPTALPG
SCHEMBL10426396 0.92 ALDH1A1 (1.00) ALDH1A1NPSR1GAAMAPTALPG
SCHEMBL10060106 0.92 ALDH1A1 (1.00) ALDH1A1NPSR1GAAMAPTALPG
SCHEMBL25286621 0.91 ALDH1A1 (0.72) ALDH1A1NPSR1GAAMAPTALPG
SCHEMBL2381086 0.89 ALDH1A1 (0.77) ALDH1A1NPSR1GAAMAPTALPG
SCHEMBL5835268 0.87 ALDH1A1 (0.67) ALDH1A1NPSR1GAAMAPTALPG
Water SCHEMBL22228992 0.86 ALDH1A1 (0.74) ALDH1A1NPSR1GAAMAPTALPG
Hydrogen Peroxide SCHEMBL8527081 0.86 ALDH1A1 (0.82) ALDH1A1NPSR1GAAMAPTALPG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115279737-A Improved synthesis of 4-amino-6- (heterocyclic) picolinates 科迪华农业科技有限责任公司 2022-11-01 CN claimed
US-4902833-A Bisphosphine dioxides UNION CARBIDE CHEMICALS AND PLASTICS COMPANY INC. (US) 1990-02-20 US claimed
US-20250320221-A1 NOVEL INTERMEDIATE, METHOD FOR PREPARING THE SAME AND APPLICATION THEREOF UNIV SICHUAN (CN) 2025-10-16 US disclosed
US-20250074925-A1 RARE EARTH COMPLEX SAGAMI CHEMICAL RESEARCH INSTITUTE (JP) 2025-03-06 US disclosed
EP-4365180-A1 RARE EARTH COMPLEX Tosoh Corporation (JP) 2024-05-08 EP disclosed
US-20230250282-A1 RESIN COMPOSITION, PREPREG, FILM WITH RESIN, METAL FOIL WITH RESIN, METAL-CLAD LAMINATE, AND PRINTED WIRING BOARD PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) 2023-08-10 US disclosed
US-20230250282-A1 RESIN COMPOSITION, PREPREG, FILM WITH RESIN, METAL FOIL WITH RESIN, METAL-CLAD LAMINATE, AND PRINTED WIRING BOARD PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) 2023-08-10 US disclosed
WO-2023282236-A1 RARE EARTH COMPLEX 東ソー株式会社 2023-01-12 WO disclosed
CN-115298167-A Improved synthesis of 6-aryl-4-aminopicolinates 科迪华农业科技有限责任公司 2022-11-04 CN disclosed
CN-115279737-A Improved synthesis of 4-amino-6- (heterocyclic) picolinates 科迪华农业科技有限责任公司 2022-11-01 CN disclosed
US-11355721-B2 Organic light emitting device comprising polar matrix, metal dopant and silver cathode NOVALED GMBH (DE) 2022-06-07 US disclosed
US-7553556-B2 Organometallic materials and electroluminescent devices EASTMAN KODAK COMPANY (US) 2009-06-30 US disclosed
US-20090069287-A1 SUBSTITUTED AZACYCLOALKANES USEFUL FOR TREATING CNS CONDITIONS PFIZER INC 2009-03-12 US disclosed
EP-0734383-B1 CYCLIC AMIDE DERIVATIVES AS NEUROKININ A ANTAGONISTS ASTRAZENECA AB (SE) 2002-07-24 EP disclosed
EP-0931086-B1 TETRAHYDRONAPHTHALENE DERIVATIVES AND THEIR THERAPEUTIC USE DARWIN DISCOVERY LTD (GB) 2002-05-02 EP disclosed
US-6133240-A INHIBITION OF SELECTINS, AND THUS OF CELL ADHESION DARWIN DISCOVERY, LTD. (GB) 2000-10-17 US disclosed
US-5965576-A Cyclic amide derivatives for treating asthma ZENECA LIMITED (GB) 1999-10-12 US disclosed
US-5705505-A Cyclic amide derivatives for treating asthma ZENECA LIMITED (GB) 1998-01-06 US disclosed
US-5589489-A Cyclic amide derivatives for treating asthma ZENECA LIMITED (GB) 1996-12-31 US disclosed
US-4902833-A Bisphosphine dioxides UNION CARBIDE CHEMICALS AND PLASTICS COMPANY INC. (US) 1990-02-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069287-A1 SUBSTITUTED AZACYCLOALKANES USEFUL FOR TREATING CNS CONDITIONS BACE2, BACE1, PMP22 ALDH1A1 1601/4885NPSR1 696/4885GAA 43/4885
US-20250320221-A1 NOVEL INTERMEDIATE, METHOD FOR PREPARING THE SAME AND APPLICATION THEREOF OPRK1, OPRM1, OPRD1 ALDH1A1 127/4885NPSR1 792/4885GAA 2226/4885
US-20250074925-A1 RARE EARTH COMPLEX L1CAM, CHRM1, NPM1 ALDH1A1 2286/4885NPSR1 720/4885GAA 2692/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.